These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29463592)

  • 1. Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.
    He S; Wang M; Si J; Zhang T; Cui H; Gao X
    BMJ Open; 2018 Feb; 8(2):e020434. PubMed ID: 29463592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of acupuncture on childhood attention deficit hyperactivity disorder: A protocol for systematic review and meta-analysis.
    Lin Y; Jin H; Huang B; Zhao N; Li Z; Mao J; Chen C; Xu J; Zhang J; Shuai B
    Medicine (Baltimore); 2021 Feb; 100(5):e23953. PubMed ID: 33592848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ginkgo preparation in patients with vascular dementia: A protocol for systematic review and meta-analysis.
    Wang M; Peng H; Peng Z; Huang K; Li T; Li L; Wu X; Shi H
    Medicine (Baltimore); 2020 Sep; 99(37):e22209. PubMed ID: 32925798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
    BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis.
    Zhou P; Yu X; Song T; Hou X
    PLoS One; 2024; 19(3):e0296926. PubMed ID: 38547138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents.
    Li S; Yu B; Zhou D; He C; Kang L; Wang X; Jiang S; Chen X
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007839. PubMed ID: 21491402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol.
    Karpouzis F; Pollard H; Bonello R
    Trials; 2009 Jan; 10():6. PubMed ID: 19173743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study.
    Lyon MR; Cline JC; Totosy de Zepetnek J; Shan JJ; Pang P; Benishin C
    J Psychiatry Neurosci; 2001 May; 26(3):221-8. PubMed ID: 11394191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhoea: protocol for a systematic review of randomised controlled trials.
    Jo J; Leem J; Lee JM; Park KS
    BMJ Open; 2017 Jun; 7(6):e015056. PubMed ID: 28619773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.
    Lahey BB; Pelham WE; Chronis A; Massetti G; Kipp H; Ehrhardt A; Lee SS
    J Child Psychol Psychiatry; 2006 May; 47(5):472-9. PubMed ID: 16671930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acupuncture for treating attention deficit hyperactivity disorder in children: A protocol for systematic review and meta-analysis.
    Kim JT; Kim K; Ang L; Lee HW; Choi JY; Lee MS
    PLoS One; 2022; 17(10):e0275504. PubMed ID: 36215241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
    Kaplan S; Heiligenstein J; West S; Busner J; Harder D; Dittmann R; Casat C; Wernicke JF
    J Atten Disord; 2004 Oct; 8(2):45-52. PubMed ID: 15801334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture treatment on attention deficit hyperactivity disorder: A protocol for systematic review and meta-analysis.
    Xing L; Ren Z; Yue X; Chen H; Xia C; Liu F; Dong Q; Wu K; Zhao R
    Medicine (Baltimore); 2021 Aug; 100(34):e27033. PubMed ID: 34449482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Lannes A; Farhat LC; Del Giovane C; Cipriani A; Revet A; Cortese S
    BMJ Open; 2022 Sep; 12(9):e062748. PubMed ID: 36167386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualised stepwise adaptive treatment for 3-6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the consortium ESCAlife.
    Becker K; Banaschewski T; Brandeis D; Dose C; Hautmann C; Holtmann M; Jans T; Jendreizik L; Jenkner C; John K; Ketter J; Millenet S; Pauli-Pott U; Renner T; Romanos M; Treier AK; von Wirth E; Wermter AK; Döpfner M
    Trials; 2020 Jan; 21(1):56. PubMed ID: 31918739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.